Purpose: The pharmacology, pharmaceutics, clinical efficacy, adverse effects, cost, and dosage and administration of long-acting risperidone injection are reviewed. Summary: Risperidone is the first ...
John M. Kane, MD: In my opinion we should start the conversation about long-acting formulations, long-acting injectable formulations, before the first relapse. I think we should be talking about it ...
The FDA approval was supported by data from the BLISS-SC Phase 3 study (n>800) in patients with active SLE. GlaxoSmithKline announced that the Food and Drug Administration (FDA) has approved Benlysta ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results